regulatory
confidence high
sentiment negative
materiality 0.85
ENDRA Life Sciences Inc. (NDRA): Nasdaq/NYSE listing notice — ENDRA receives Nasdaq delisting notice for equity falling below $2.5M minimum
ENDRA Life Sciences Inc.
- Nasdaq notified ENDRA on Apr 20, 2026 that stockholders' equity of $2,260,120 as of Dec 31, 2025 fails the $2.5M minimum.
- Company intends to timely request a hearing before Nasdaq Hearings Panel to stay delisting.
- ENDRA previously regained compliance in Nov 2025 but is now non-compliant again after annual report filing.
- No assurance that the company will regain compliance or succeed in appeal; delisting remains possible.